Results 281 to 290 of about 242,018 (356)
Comprehensive Review of Early and Late Toxicities in CAR T-Cell Therapy and Bispecific Antibody Treatments for Hematologic Malignancies. [PDF]
Bangolo A+6 more
europepmc +1 more source
Cross‐species extrapolation of adverse outcome pathway network on reproductive toxicity under the One Health perspective using new approach methodologies. AOP = adverse outcome pathway. Abstract Although ecotoxicological and toxicological risk assessments are performed separately from each other, recent efforts have been made in both disciplines to ...
Elizabeth Dufourcq Sekatcheff+2 more
wiley +1 more source
Multi-Omics Analysis of Hippocampus in Rats Administered Trimethyltin Chloride. [PDF]
Zakaria D, Yamashita T, Kosugi Y.
europepmc +1 more source
A Histopathological Study on Neurotoxicity of n-Hexane and Petroleum Benzine
J. Kitoh
openalex +2 more sources
Targeting the Tumor Microbiota in Cancer Therapy Basing on Nanomaterials
Intra‐tumoral microbiota, which is a potential component of the tumor microenvironment, has been emerging as a key participant and driving factor in cancer. This article reviews the latest progress in this field, including the microbial community within tumors and its pro‐cancer mechanisms, as well as the anti‐tumor strategies targeting intra‐tumoral ...
Yanan Niu+4 more
wiley +1 more source
Neuropsychiatric manifestations following chimeric antigen receptor T cell therapy for cancer: a systematic review of clinical outcomes and management strategies. [PDF]
Fleischer A+10 more
europepmc +1 more source
Monitoring Potential Neurotoxic Effects of Hazardous Waste Disposal
Herbert H. Schaumburg+2 more
openalex +1 more source
BACE1 interfering RNA, metallothionein and ruthenium complexes ([Ru(bpy)2dppz]2+) were all loaded in prussian blue nanoparticles (PRM‐siRNA). PRM‐siRNA under near‐infrared light irradiation showed good photothermal effect and triggered instantaneous opening of blood‐brain barrier for enhanced drug delivery.
Xiaoyuan Ding+9 more
wiley +1 more source
Addressing graft-versus-host disease in allogeneic cell-based immunotherapy for cancer. [PDF]
Lyu Z+5 more
europepmc +1 more source